Global Parkinson's Disease Drug Market Insights and Forecast to 2026

Global Parkinson's Disease Drug Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Parkinson's Disease Drug Product Introduction
1.2 Market Segments
1.3 Key Parkinson's Disease Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Parkinson's Disease Drug Market Size Growth Rate by Type
1.4.2 Sinemet-CR
1.4.3 Trastal
1.4.4 Madopar
1.4.5 COMT Inhibitor
1.4.6 Other
1.5 Market by Application
1.5.1 Global Parkinson's Disease Drug Market Size Growth Rate by Application
1.5.2 Under 40 Years Old
1.5.3 40-65 Years Old
1.5.4 Above 65 Years Old
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Parkinson's Disease Drug Market Size, Estimates and Forecasts
2.1.1 Global Parkinson's Disease Drug Revenue 2015-2026
2.1.2 Global Parkinson's Disease Drug Sales 2015-2026
2.2 Global Parkinson's Disease Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Parkinson's Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Parkinson's Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Parkinson's Disease Drug Competitor Landscape by Players
3.1 Parkinson's Disease Drug Sales by Manufacturers
3.1.1 Parkinson's Disease Drug Sales by Manufacturers (2015-2020)
3.1.2 Parkinson's Disease Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Parkinson's Disease Drug Revenue by Manufacturers
3.2.1 Parkinson's Disease Drug Revenue by Manufacturers (2015-2020)
3.2.2 Parkinson's Disease Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Parkinson's Disease Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Parkinson's Disease Drug Revenue in 2019
3.2.5 Global Parkinson's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Parkinson's Disease Drug Price by Manufacturers
3.4 Parkinson's Disease Drug Manufacturing Base Distribution, Product Types
3.4.1 Parkinson's Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Parkinson's Disease Drug Product Type
3.4.3 Date of International Manufacturers Enter into Parkinson's Disease Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Parkinson's Disease Drug Market Size by Type (2015-2020)
4.1.1 Global Parkinson's Disease Drug Sales by Type (2015-2020)
4.1.2 Global Parkinson's Disease Drug Revenue by Type (2015-2020)
4.1.3 Parkinson's Disease Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Parkinson's Disease Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Parkinson's Disease Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Parkinson's Disease Drug Revenue Forecast by Type (2021-2026)
4.2.3 Parkinson's Disease Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Parkinson's Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Parkinson's Disease Drug Market Size by Application (2015-2020)
5.1.1 Global Parkinson's Disease Drug Sales by Application (2015-2020)
5.1.2 Global Parkinson's Disease Drug Revenue by Application (2015-2020)
5.1.3 Parkinson's Disease Drug Price by Application (2015-2020)
5.2 Parkinson's Disease Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Parkinson's Disease Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Parkinson's Disease Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Parkinson's Disease Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Parkinson's Disease Drug by Country
6.1.1 North America Parkinson's Disease Drug Sales by Country
6.1.2 North America Parkinson's Disease Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Parkinson's Disease Drug Market Facts & Figures by Type
6.3 North America Parkinson's Disease Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Parkinson's Disease Drug by Country
7.1.1 Europe Parkinson's Disease Drug Sales by Country
7.1.2 Europe Parkinson's Disease Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Parkinson's Disease Drug Market Facts & Figures by Type
7.3 Europe Parkinson's Disease Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Parkinson's Disease Drug by Region
8.1.1 Asia Pacific Parkinson's Disease Drug Sales by Region
8.1.2 Asia Pacific Parkinson's Disease Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Parkinson's Disease Drug Market Facts & Figures by Type
8.3 Asia Pacific Parkinson's Disease Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Parkinson's Disease Drug by Country
9.1.1 Latin America Parkinson's Disease Drug Sales by Country
9.1.2 Latin America Parkinson's Disease Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Parkinson's Disease Drug Market Facts & Figures by Type
9.3 Central & South America Parkinson's Disease Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Parkinson's Disease Drug by Country
10.1.1 Middle East and Africa Parkinson's Disease Drug Sales by Country
10.1.2 Middle East and Africa Parkinson's Disease Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Parkinson's Disease Drug Market Facts & Figures by Type
10.3 Middle East and Africa Parkinson's Disease Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Parkinson's Disease Drug Products Offered
11.1.5 Merck Related Developments
11.2 Akorn
11.2.1 Akorn Corporation Information
11.2.2 Akorn Description and Business Overview
11.2.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Akorn Parkinson's Disease Drug Products Offered
11.2.5 Akorn Related Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Description and Business Overview
11.3.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GSK Parkinson's Disease Drug Products Offered
11.3.5 GSK Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description and Business Overview
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Parkinson's Disease Drug Products Offered
11.4.5 Novartis Related Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Corporation Information
11.5.2 Boehringer Ingelheim Description and Business Overview
11.5.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Boehringer Ingelheim Parkinson's Disease Drug Products Offered
11.5.5 Boehringer Ingelheim Related Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Corporation Information
11.6.2 Teva Pharmaceutical Description and Business Overview
11.6.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Teva Pharmaceutical Parkinson's Disease Drug Products Offered
11.6.5 Teva Pharmaceutical Related Developments
11.7 Abbvie
11.7.1 Abbvie Corporation Information
11.7.2 Abbvie Description and Business Overview
11.7.3 Abbvie Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Abbvie Parkinson's Disease Drug Products Offered
11.7.5 Abbvie Related Developments
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Corporation Information
11.8.2 Kyowa Hakko Kirin Pharma Description and Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Products Offered
11.8.5 Kyowa Hakko Kirin Pharma Related Developments
11.9 Astellas Pharma
11.9.1 Astellas Pharma Corporation Information
11.9.2 Astellas Pharma Description and Business Overview
11.9.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Astellas Pharma Parkinson's Disease Drug Products Offered
11.9.5 Astellas Pharma Related Developments
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Corporation Information
11.10.2 Desitin Arzneimittel Description and Business Overview
11.10.3 Desitin Arzneimittel Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Desitin Arzneimittel Parkinson's Disease Drug Products Offered
11.10.5 Desitin Arzneimittel Related Developments
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Parkinson's Disease Drug Products Offered
11.1.5 Merck Related Developments
11.12 F.Hoffmann-La Roche
11.12.1 F.Hoffmann-La Roche Corporation Information
11.12.2 F.Hoffmann-La Roche Description and Business Overview
11.12.3 F.Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.12.4 F.Hoffmann-La Roche Products Offered
11.12.5 F.Hoffmann-La Roche Related Developments
11.13 H.Lundbeck
11.13.1 H.Lundbeck Corporation Information
11.13.2 H.Lundbeck Description and Business Overview
11.13.3 H.Lundbeck Sales, Revenue and Gross Margin (2015-2020)
11.13.4 H.Lundbeck Products Offered
11.13.5 H.Lundbeck Related Developments
11.14 Valeant
11.14.1 Valeant Corporation Information
11.14.2 Valeant Description and Business Overview
11.14.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Valeant Products Offered
11.14.5 Valeant Related Developments
11.15 Apokyn
11.15.1 Apokyn Corporation Information
11.15.2 Apokyn Description and Business Overview
11.15.3 Apokyn Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Apokyn Products Offered
11.15.5 Apokyn Related Developments
11.16 Orion
11.16.1 Orion Corporation Information
11.16.2 Orion Description and Business Overview
11.16.3 Orion Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Orion Products Offered
11.16.5 Orion Related Developments
11.17 Stada Arzneimittel
11.17.1 Stada Arzneimittel Corporation Information
11.17.2 Stada Arzneimittel Description and Business Overview
11.17.3 Stada Arzneimittel Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Stada Arzneimittel Products Offered
11.17.5 Stada Arzneimittel Related Developments
11.18 US WorldMeds
11.18.1 US WorldMeds Corporation Information
11.18.2 US WorldMeds Description and Business Overview
11.18.3 US WorldMeds Sales, Revenue and Gross Margin (2015-2020)
11.18.4 US WorldMeds Products Offered
11.18.5 US WorldMeds Related Developments
11.19 Bausch Health
11.19.1 Bausch Health Corporation Information
11.19.2 Bausch Health Description and Business Overview
11.19.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Bausch Health Products Offered
11.19.5 Bausch Health Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Parkinson's Disease Drug Market Estimates and Projections by Region
12.1.1 Global Parkinson's Disease Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Parkinson's Disease Drug Revenue Forecast by Regions 2021-2026
12.2 North America Parkinson's Disease Drug Market Size Forecast (2021-2026)
12.2.1 North America: Parkinson's Disease Drug Sales Forecast (2021-2026)
12.2.2 North America: Parkinson's Disease Drug Revenue Forecast (2021-2026)
12.2.3 North America: Parkinson's Disease Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Parkinson's Disease Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Parkinson's Disease Drug Sales Forecast (2021-2026)
12.3.2 Europe: Parkinson's Disease Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Parkinson's Disease Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Parkinson's Disease Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Parkinson's Disease Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Parkinson's Disease Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Parkinson's Disease Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Parkinson's Disease Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Parkinson's Disease Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Parkinson's Disease Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Parkinson's Disease Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Parkinson's Disease Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Parkinson's Disease Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Parkinson's Disease Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Parkinson's Disease Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Parkinson's Disease Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Parkinson's Disease Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Parkinson's Disease Drug Market Segments
Table 2. Ranking of Global Top Parkinson's Disease Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Parkinson's Disease Drug Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Sinemet-CR
Table 5. Major Manufacturers of Trastal
Table 6. Major Manufacturers of Madopar
Table 7. Major Manufacturers of COMT Inhibitor
Table 8. Major Manufacturers of Other
Table 9. Global Parkinson's Disease Drug Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 10. Global Parkinson's Disease Drug Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 11. Global Parkinson's Disease Drug Sales by Regions 2015-2020 (K Doses)
Table 12. Global Parkinson's Disease Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Parkinson's Disease Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Parkinson's Disease Drug Sales by Manufacturers (2015-2020) (K Doses)
Table 15. Global Parkinson's Disease Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Parkinson's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Parkinson's Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Drug as of 2019)
Table 18. Parkinson's Disease Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Parkinson's Disease Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Parkinson's Disease Drug Price (2015-2020) (USD/Dose)
Table 21. Parkinson's Disease Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Parkinson's Disease Drug Product Type
Table 23. Date of International Manufacturers Enter into Parkinson's Disease Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Parkinson's Disease Drug Sales by Type (2015-2020) (K Doses)
Table 26. Global Parkinson's Disease Drug Sales Share by Type (2015-2020)
Table 27. Global Parkinson's Disease Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Parkinson's Disease Drug Revenue Share by Type (2015-2020)
Table 29. Parkinson's Disease Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 30. Global Parkinson's Disease Drug Sales by Application (2015-2020) (K Doses)
Table 31. Global Parkinson's Disease Drug Sales Share by Application (2015-2020)
Table 32. North America Parkinson's Disease Drug Sales by Country (2015-2020) (K Doses)
Table 33. North America Parkinson's Disease Drug Sales Market Share by Country (2015-2020)
Table 34. North America Parkinson's Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Parkinson's Disease Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Parkinson's Disease Drug Sales by Type (2015-2020) (K Doses)
Table 37. North America Parkinson's Disease Drug Sales Market Share by Type (2015-2020)
Table 38. North America Parkinson's Disease Drug Sales by Application (2015-2020) (K Doses)
Table 39. North America Parkinson's Disease Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Parkinson's Disease Drug Sales by Country (2015-2020) (K Doses)
Table 41. Europe Parkinson's Disease Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Parkinson's Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Parkinson's Disease Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Parkinson's Disease Drug Sales by Type (2015-2020) (K Doses)
Table 45. Europe Parkinson's Disease Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Parkinson's Disease Drug Sales by Application (2015-2020) (K Doses)
Table 47. Europe Parkinson's Disease Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Parkinson's Disease Drug Sales by Region (2015-2020) (K Doses)
Table 49. Asia Pacific Parkinson's Disease Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Parkinson's Disease Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Parkinson's Disease Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Parkinson's Disease Drug Sales by Type (2015-2020) (K Doses)
Table 53. Asia Pacific Parkinson's Disease Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Parkinson's Disease Drug Sales by Application (2015-2020) (K Doses)
Table 55. Asia Pacific Parkinson's Disease Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Parkinson's Disease Drug Sales by Country (2015-2020) (K Doses)
Table 57. Latin America Parkinson's Disease Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Parkinson's Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Parkinson's Disease Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Parkinson's Disease Drug Sales by Type (2015-2020) (K Doses)
Table 61. Latin America Parkinson's Disease Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Parkinson's Disease Drug Sales by Application (2015-2020) (K Doses)
Table 63. Latin America Parkinson's Disease Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Parkinson's Disease Drug Sales by Country (2015-2020) (K Doses)
Table 65. Middle East and Africa Parkinson's Disease Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Parkinson's Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Parkinson's Disease Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Parkinson's Disease Drug Sales by Type (2015-2020) (K Doses)
Table 69. Middle East and Africa Parkinson's Disease Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Parkinson's Disease Drug Sales by Application (2015-2020) (K Doses)
Table 71. Middle East and Africa Parkinson's Disease Drug Sales Market Share by Application (2015-2020)
Table 72. Merck Corporation Information
Table 73. Merck Description and Major Businesses
Table 74. Merck Parkinson's Disease Drug Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 75. Merck Product
Table 76. Merck Recent Development
Table 77. Akorn Corporation Information
Table 78. Akorn Description and Major Businesses
Table 79. Akorn Parkinson's Disease Drug Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 80. Akorn Product
Table 81. Akorn Recent Development
Table 82. GSK Corporation Information
Table 83. GSK Description and Major Businesses
Table 84. GSK Parkinson's Disease Drug Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 85. GSK Product
Table 86. GSK Recent Development
Table 87. Novartis Corporation Information
Table 88. Novartis Description and Major Businesses
Table 89. Novartis Parkinson's Disease Drug Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 90. Novartis Product
Table 91. Novartis Recent Development
Table 92. Boehringer Ingelheim Corporation Information
Table 93. Boehringer Ingelheim Description and Major Businesses
Table 94. Boehringer Ingelheim Parkinson's Disease Drug Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 95. Boehringer Ingelheim Product
Table 96. Boehringer Ingelheim Recent Development
Table 97. Teva Pharmaceutical Corporation Information
Table 98. Teva Pharmaceutical Description and Major Businesses
Table 99. Teva Pharmaceutical Parkinson's Disease Drug Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 100. Teva Pharmaceutical Product
Table 101. Teva Pharmaceutical Recent Development
Table 102. Abbvie Corporation Information
Table 103. Abbvie Description and Major Businesses
Table 104. Abbvie Parkinson's Disease Drug Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 105. Abbvie Product
Table 106. Abbvie Recent Development
Table 107. Kyowa Hakko Kirin Pharma Corporation Information
Table 108. Kyowa Hakko Kirin Pharma Description and Major Businesses
Table 109. Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 110. Kyowa Hakko Kirin Pharma Product
Table 111. Kyowa Hakko Kirin Pharma Recent Development
Table 112. Astellas Pharma Corporation Information
Table 113. Astellas Pharma Description and Major Businesses
Table 114. Astellas Pharma Parkinson's Disease Drug Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 115. Astellas Pharma Product
Table 116. Astellas Pharma Recent Development
Table 117. Desitin Arzneimittel Corporation Information
Table 118. Desitin Arzneimittel Description and Major Businesses
Table 119. Desitin Arzneimittel Parkinson's Disease Drug Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 120. Desitin Arzneimittel Product
Table 121. Desitin Arzneimittel Recent Development
Table 122. Endo Pharmaceuticals Corporation Information
Table 123. Endo Pharmaceuticals Description and Major Businesses
Table 124. Endo Pharmaceuticals Parkinson's Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 125. Endo Pharmaceuticals Product
Table 126. Endo Pharmaceuticals Recent Development
Table 127. F.Hoffmann-La Roche Corporation Information
Table 128. F.Hoffmann-La Roche Description and Major Businesses
Table 129. F.Hoffmann-La Roche Parkinson's Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 130. F.Hoffmann-La Roche Product
Table 131. F.Hoffmann-La Roche Recent Development
Table 132. H.Lundbeck Corporation Information
Table 133. H.Lundbeck Description and Major Businesses
Table 134. H.Lundbeck Parkinson's Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 135. H.Lundbeck Product
Table 136. H.Lundbeck Recent Development
Table 137. Valeant Corporation Information
Table 138. Valeant Description and Major Businesses
Table 139. Valeant Parkinson's Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 140. Valeant Product
Table 141. Valeant Recent Development
Table 142. Apokyn Corporation Information
Table 143. Apokyn Description and Major Businesses
Table 144. Apokyn Parkinson's Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 145. Apokyn Product
Table 146. Apokyn Recent Development
Table 147. Orion Corporation Information
Table 148. Orion Description and Major Businesses
Table 149. Orion Parkinson's Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 150. Orion Product
Table 151. Orion Recent Development
Table 152. Stada Arzneimittel Corporation Information
Table 153. Stada Arzneimittel Description and Major Businesses
Table 154. Stada Arzneimittel Parkinson's Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 155. Stada Arzneimittel Product
Table 156. Stada Arzneimittel Recent Development
Table 157. US WorldMeds Corporation Information
Table 158. US WorldMeds Description and Major Businesses
Table 159. US WorldMeds Parkinson's Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 160. US WorldMeds Product
Table 161. US WorldMeds Recent Development
Table 162. Bausch Health Corporation Information
Table 163. Bausch Health Description and Major Businesses
Table 164. Bausch Health Parkinson's Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 165. Bausch Health Product
Table 166. Bausch Health Recent Development
Table 167. Global Parkinson's Disease Drug Sales Forecast by Regions (2021-2026) (K Doses)
Table 168. Global Parkinson's Disease Drug Sales Market Share Forecast by Regions (2021-2026)
Table 169. Global Parkinson's Disease Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 170. Global Parkinson's Disease Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 171. North America: Parkinson's Disease Drug Sales Forecast by Country (2021-2026) (K Doses)
Table 172. North America: Parkinson's Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 173. Europe: Parkinson's Disease Drug Sales Forecast by Country (2021-2026) (K Doses)
Table 174. Europe: Parkinson's Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 175. Asia Pacific: Parkinson's Disease Drug Sales Forecast by Region (2021-2026) (K Doses)
Table 176. Asia Pacific: Parkinson's Disease Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 177. Latin America: Parkinson's Disease Drug Sales Forecast by Country (2021-2026) (K Doses)
Table 178. Latin America: Parkinson's Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 179. Middle East and Africa: Parkinson's Disease Drug Sales Forecast by Country (2021-2026) (K Doses)
Table 180. Middle East and Africa: Parkinson's Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 181. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 182. Key Challenges
Table 183. Market Risks
Table 184. Main Points Interviewed from Key Parkinson's Disease Drug Players
Table 185. Parkinson's Disease Drug Customers List
Table 186. Parkinson's Disease Drug Distributors List
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Parkinson's Disease Drug Product Picture
Figure 2. Global Parkinson's Disease Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Sinemet-CR Product Picture
Figure 4. Trastal Product Picture
Figure 5. Madopar Product Picture
Figure 6. COMT Inhibitor Product Picture
Figure 7. Other Product Picture
Figure 8. Global Parkinson's Disease Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Under 40 Years Old
Figure 10. 40-65 Years Old
Figure 11. Above 65 Years Old
Figure 12. Parkinson's Disease Drug Report Years Considered
Figure 13. Global Parkinson's Disease Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Parkinson's Disease Drug Sales 2015-2026 (K Doses)
Figure 15. Global Parkinson's Disease Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Parkinson's Disease Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Parkinson's Disease Drug Sales Market Share by Region in 2019
Figure 18. Global Parkinson's Disease Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Parkinson's Disease Drug Revenue Market Share by Region in 2019
Figure 20. Global Parkinson's Disease Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Parkinson's Disease Drug Revenue in 2019
Figure 22. Parkinson's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Parkinson's Disease Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Parkinson's Disease Drug Sales Market Share by Type in 2019
Figure 25. Global Parkinson's Disease Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Parkinson's Disease Drug Revenue Market Share by Type in 2019
Figure 27. Global Parkinson's Disease Drug Market Share by Price Range (2015-2020)
Figure 28. Global Parkinson's Disease Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Parkinson's Disease Drug Sales Market Share by Application in 2019
Figure 30. Global Parkinson's Disease Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Parkinson's Disease Drug Revenue Market Share by Application in 2019
Figure 32. North America Parkinson's Disease Drug Sales Growth Rate 2015-2020 (K Doses)
Figure 33. North America Parkinson's Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Parkinson's Disease Drug Sales Market Share by Country in 2019
Figure 35. North America Parkinson's Disease Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 37. U.S. Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 39. Canada Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Parkinson's Disease Drug Market Share by Type in 2019
Figure 41. North America Parkinson's Disease Drug Market Share by Application in 2019
Figure 42. Europe Parkinson's Disease Drug Sales Growth Rate 2015-2020 (K Doses)
Figure 43. Europe Parkinson's Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Parkinson's Disease Drug Sales Market Share by Country in 2019
Figure 45. Europe Parkinson's Disease Drug Revenue Market Share by Country in 2019
Figure 46. Germany Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 47. Germany Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 49. France Parkinson's Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Parkinson's Disease Drug Sales Growth Rate (2015-2020) (K Doses)
Figure 51. U.K. P

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs